J C

The Canadian Medical Association’s journal published a new study in late November titled, “Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study.”

The researchers studied 10 million doses of the shots and found an overall average rate of new myocarditis cases in people who got the mRNA vaccine, at a rate of 141 per 100,000, or 1 in 6,500 — just within the first 21 days following injection.

That is insanely high.

Worse, they found the highest rate of heart damage among young males aged 18-29 who got Moderna, which features a higher mRNA payload than Pfizer.

The study authors counted myocarditis cases based on hospital admissions and ER visits. In other words, they DIDN’T count subclinical cases not requiring a hospital visit within the first 21 days, or cases diagnosed outside a hospital. So the numbers are almost certainly understated.

But of course, the authors covered for the jabs. They had to, to get published. Here’s how they justified the risk:

According to a US analysis, 11,000 COVID-19 cases, 560 hospital admissions, 138 ICU admissions and 6 deaths from COVID-19 could be prevented per million-second doses of mRNA SARS-CoV-2 vaccine administered to males aged 12–29 years, compared with 39–47 expected cases of myocarditis after SARS-CoV-2 vaccination.
So, take one for the team! It’s the classic ethical dilemma. Assuming those numbers are accurate, is it morally permissible to intentionally give 50 people permanent heart disease in order to prevent six deaths?